Navigation Links
Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
Date:10/8/2007

BERKELEY HEIGHTS, N.J., Oct. 8 /PRNewswire/ -- Clinsys Clinical Research, Inc., a therapeutically focused clinical research organization, today announced the relocation of its corporate headquarters to accommodate the company's significant growth and plans for future expansion. The new, larger facility is located in Bedminster, New Jersey.

"Our new headquarters, combined with our recent expansion of operations in Raleigh, North Carolina and Dusseldorf, Germany, offers many advantages to Clinsys and our sponsors," said David E. Williams, Chief Executive Officer of Clinsys Clinical Research. Mr. Williams continues, "The relocation strategically keeps Clinsys in the center of one of the largest biopharmaceutical clusters and experienced employee pools in the country. Our new headquarters will afford us enhanced operational performance from which to continue to provide exceptional service to our existing and new sponsors."

Clinsys will occupy the new facility on Monday, October 15. The new address is:

One Crossroads Drive, Building A, Second Floor, Bedminster, New Jersey 07921.

The new corporate telephone number is +1 908 947 7777.

The new corporate fax number is +1 908 947 7953.

About Clinsys Clinical Research, Inc.

Clinsys Clinical Research, Inc.(R), is a therapeutically focused clinical research organization and a Jubilant Organosys company, headquartered in Bedminster, New Jersey. Clinsys has operations in Raleigh, North Carolina; Philadelphia, Pennsylvania; Dusseldorf, Germany; Gent, Belgium; Noida and Bangalore, India. Clinsys provides pharmaceutical and biotechnology companies a broad range of clinical research services in support of Phase I -- IV drug development: project management, medical and clinical monitoring, investigator and patient recruitment, site management, biostatistics, data management, drug safety, quality assurance, regulatory affairs and medical writing services. Clinsys has expertise in a wide range of highly specialized therapeutic areas including oncology, cardiovascular, central nervous system, dermatology, respiratory, and allergy/immunology. Clinsys Clinical Research, Ltd., located in Noida, India, provides extensive clinical research services for Phase I -- IV drug development, and operates a clinical pharmacology unit which performs bioavailability and bioequivalence studies as well as bioanalytical sample analysis, clinical laboratory and pathology services. Targeted Clinical Staffing Solutions(R) (TCSS -- gotcss.com), a division of Clinsys Clinical Research, Inc., is a provider of professional staffing solutions and innovative partnering programs for the life sciences industry. For more information visit clinsyscro.com.

About Jubilant Organosys, Ltd.

Jubilant Organosys is an integrated pharmaceutical services provider, one of the largest custom research and manufacturing services (CRAMS), drug discovery and development services companies headquartered in India. Jubilant Organosys has more than 4,300 employees across organizations in India, the United States, Europe and China. It has four manufacturing locations in India and two in the United States. For more information visit jubl.com.

Clinsys Clinical Research and Targeted Clinical Staffing Solutions are registered trademarks of Clinsys Clinical Research, Inc.

Contact: Colin Coffua -- Vice President, Global Marketing

+1 908 464 7500

ccoffua@clinsyscro.com


'/>"/>
SOURCE Clinsys Clinical Research, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BioRobot MDx standardize your automated protocols in clinical laboratories
2. What patients want: A story of choice, clinical trials & evidence-based medicine
3. ZyStor seeks to raise $15M for clinical trials
4. Prodesse begins clinical trials for flu virus detection
5. ConjuGon raises $3.3 million to fund clinical trials
6. Cancer-fighting agent heads for clinical trials
7. Quintessence cancer treatment chosen for clinical studies
8. Third Wave reports clinical growth, continued loss
9. Childrens expanding use of Sunrise Clinical Manager
10. Life-sciences conference to feature novel research with clinical potential
11. $14 million grant to drive clinical research at UW
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... HOUSTON , June 23, 2016 ... agreement with the Cy-Fair Sports Association to serve ... of the agreement, Houston Methodist Willowbrook will provide ... education and connectivity with association coaches, volunteers, athletes ... partner with the Cy-Fair Sports Association and to ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
Breaking Biology News(10 mins):